1022931-76-5

Basic information

• Product Name: 4-[3-(trifluoromethyl)-6,7-dihydropyrano[4,3-c]pyrazol-1(4H)-yl]benzoic acid
• Synonyms: 4-[3-(trifluoromethyl)-6,7-dihydropyrano[4,3-c]pyrazol-1(4H)-yl]benzoic acid
• CAS NO: 1022931-76-5
• Molecular Weight: 312.248
• Mol File: 1022931-76-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[3-(trifluoromethyl)-6,7-dihydropyrano[4,3-c]pyrazol-1(4H)-yl]benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[3-(trifluoromethyl)-6,7-dihydropyrano[4,3-c]pyrazol-1(4H)-yl]benzoic acid(1022931-76-5)
• EPA Substance Registry System: 4-[3-(trifluoromethyl)-6,7-dihydropyrano[4,3-c]pyrazol-1(4H)-yl]benzoic acid(1022931-76-5)

Safety Data

• Hazardous Substances Data: 1022931-76-5(Hazardous Substances Data)

Upstream product

• 1022931-45-8 3-(trifluoromethyl)-1,4,6,7-tetrahydropyrano[4,3-c]pyrazole 
• 619-58-9 4-iodobenzoic acid 

Downstream Products

• 1022930-70-6 1-[4-(1-azetidinylcarbonyl)phenyl]-3-(trifluoromethyl)-1,4,6,7-tetrahydropyrano[4,3-c]pyrazole 

Relevant articles and documents

COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

Compounds of formula (I), and salts and solvates thereof are provided: Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.